Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Anders Bröijersén"'
Publikováno v:
Journal of Lipid Research, Vol 56, Iss 8, Pp 1633-1639 (2015)
At a given level of serum cholesterol, patients with T2D have an increased risk of developing atherosclerosis compared with nondiabetic subjects. We hypothesized that T2D patients have an increased interstitial fluid (IF)-to-serum gradient ratio for
Externí odkaz:
https://doaj.org/article/594b1d91656c4d34a91b98bf43a386c5
Autor:
Paul Harmatz, Joseph Muenzer, Fatih Ezgü, Per Dalén, Gunilla Huledal, Daniel Lindqvist, Stefan Svensson Gelius, Margareta Wikén, Kristin Önnestam, Anders Bröijersén
Publikováno v:
Molecular Genetics and Metabolism. 136:249-259
Mucopolysaccharidosis IIIA (MPS IIIA) is an inherited lysosomal storage disorder caused by mutations in the N-sulfoglucosamine sulfohydrolase gene that result in deficient enzymatic degradation of heparan sulfate (HS), resulting in progressive neurod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df4c4d9fbee3c4f24da84f9d83f79ec
https://doi.org/10.1016/j.ymgme.2022.06.008
https://doi.org/10.1016/j.ymgme.2022.06.008
Autor:
James A. Gallagher, Michael E. Briggs, Elizabeth Záňová, Birgitta Olsson, Ciarán Scott, Mattias Rudebeck, Sophie Taylor, Nadia Loftus, Nicolas Sireau, Brendan P. Norman, Roman Stančík, Jozef Rovenský, Alpesh Mistry, Andrew S. Davison, Elizabeth West, Richard Imrich, Nick Rhodes, Michael Fisher, Kim Hanh Le Quan Sang, Christa van Kan, Juliette H. Hughes, Emily Luangrath, J.P. Dillon, Jonathan C. Jarvis, Ol'ga Lukáčová, Eftychia E. Psarelli, Dinny Laan, Anthony K Hall, Trevor Cox, Andrea Zatkova, Anna M. Milan, Eva Vrtíková, Richard Fitzgerald, Jean Baptiste Arnoux, Helena Glasova, Jana Sedláková, Johan Szamosi, Lakshminarayan R. Ranganath, Daniela Braconi, Federica Genovese, Chris Webb, Milad Khedr, Anders Bröijersén, Vanda Mlynáriková, Helen Bygott, Annalisa Santucci, Sobhan Vinjamuri, Ella Shweihdi, Andrew T. Hughes
Publikováno v:
The Lancet Diabetes and Endocrinology
Background Alkaptonuria is a rare, genetic, multisystem disease characterised by the accumulation of homogentisic acid (HGA). No HGA-lowering therapy has been approved to date. The aim of SONIA 2 was to investigate the efficacy and safety of once-dai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3375e22d6a501121aedc7298d351ee0f
https://pubmed.ncbi.nlm.nih.gov/32822600
https://pubmed.ncbi.nlm.nih.gov/32822600
Publikováno v:
Blood Coagulation & Fibrinolysis. 27:113-116
Impaired fibrinolysis is related to insulin resistance, also a characteristic feature of familial combined hyperlipidemia (FCHL). The renin-angiotensin (Ang) system is upregulated with insulin resistance, and there is crosstalk between Ang II and ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e16703ae4f1e519e01290839da4a7f72
https://doi.org/10.1097/mbc.0000000000000393
https://doi.org/10.1097/mbc.0000000000000393
Autor:
Anders Bröijersén, Birgitta Olsson, Per Dalén, Matthias Kruse, Daniel Lindqvist, Gunilla Huledal, Kristin Önnestam
Publikováno v:
European journal of clinical pharmacology. 75(3)
Nitisinone inhibits the cytochrome P450 (CYP) subfamilies CYP2C9, CYP2D6, and CYP2E1 and the organic anion transporter (OAT) isoforms OAT1 and OAT3 in vitro. Since the effect of nitisinone on these enzymes and transporters in humans is still unknown,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ab8db23bf0d1fa7ffab85e2ee09b21
https://pubmed.ncbi.nlm.nih.gov/30443705
https://pubmed.ncbi.nlm.nih.gov/30443705
Publikováno v:
JIMD Reports ISBN: 9783662566091
Background: Although nitisinone is successfully used to treat hereditary tyrosinemia type 1 (HT-1) with the recommended twice-daily dosing, data describing a long half-life motivate less frequent dosing. Therefore, in agreement with the Pharmacovigil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de6fedaae81b555a9d0d48f1506f7b7a
https://doi.org/10.1007/8904_2017_29
https://doi.org/10.1007/8904_2017_29
Autor:
Gunilla Huledal, Margareta Wikén, Daniel Lindqvist, Fatih Süheyl Ezgü, Per Dalén, Paul Harmatz, Anders Bröijersén
Publikováno v:
Molecular Genetics and Metabolism. 126:S34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb88109e851f8cfb3de269400dd95c6b
https://doi.org/10.1016/j.ymgme.2018.12.066
https://doi.org/10.1016/j.ymgme.2018.12.066
Publikováno v:
Thrombosis Research. 124:110-115
Angiotensin (Ang) II may be involved in the development of cardiovascular disease. We examined the potential proinflammatory and prothrombotic effects of Ang II in 16 healthy subjects and in 16 subjects with familial combined hyperlipidemia (FCHL), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3b4f78a279a383ed4db1101217f48d7
https://doi.org/10.1016/j.thromres.2008.12.040
https://doi.org/10.1016/j.thromres.2008.12.040
Publikováno v:
European Journal of Clinical Investigation. 36:98-104
Background High-quality methods for lipoprotein characterization are warranted in studies on various metabolic diseases. Materials and methods An automated system for size-exclusion chromatography (SEC) of lipoproteins using commercially available co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf80375df523aa6922fb38405cfdbc53
https://doi.org/10.1111/j.1365-2362.2006.01597.x
https://doi.org/10.1111/j.1365-2362.2006.01597.x
Publikováno v:
British Journal of Pharmacology. 144:860-866
1 Endothelin (ET) receptor antagonists are cardioprotective during myocardial ischaemia and reperfusion through a nitric oxide (NO)-dependent mechanism. The aim of the present study was to investigate whether the ET receptor antagonist, bosentan, is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::426c471628be3b07dfc6c420585e0cd5
https://doi.org/10.1038/sj.bjp.0706117
https://doi.org/10.1038/sj.bjp.0706117